← 返回

双缺陷富氮氮化碳基异质结构纳米催化剂通过重塑肿瘤免疫微环境提高αPD-1 的治疗效果

英文原题:Dual-Defect Nitrogen-Rich Carbon Nitride-Based Heterostructural Nanocatalyst for Improving the Therapeutic Efficacy of αPD-1 via Tumor Immune Microenvironment Remodelling.

查看英文原题

Dual-Defect Nitrogen-Rich Carbon Nitride-Based Heterostructural Nanocatalyst for Improving the Therapeutic Efficacy of αPD-1 via Tumor Immune Microenvironment Remodelling.

PubMed 2025/06/04(内容时间) Adv Mater Q1 · IF 29.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

低免疫原性、免疫浸润不足以及肿瘤抑制性微环境无情地削弱了免疫疗法的治疗效果。如何通过重塑肿瘤免疫微环境来提高治疗效果仍然是一个亟待解决的挑战。

在此,开发了一种新型双缺陷富氮碳氮化物基异质结构纳米催化剂(CNO@CuMS),具有出色的压电催化H2O2生成、声催化1O2生成、类Fenton催化•OH生成以及诱导细胞铜死亡的性质。在超声处理伴随下,CNO@CuMS成功触发了肿瘤细胞的免疫原性细胞死亡(ICD)及随后损伤相关分子模式(DAMPs)的释放,从而激活了系统性抗肿瘤反应并增强了肿瘤部位CD8+细胞毒性T淋巴细胞和自然杀伤(NK)细胞的浸润。大量定量生成的活性氧(ROS)也促进了M2型巨噬细胞向M1型的极化。受益于这种肿瘤免疫微环境重塑效应,在超声处理下采用CNO@CuMS + αPD-1联合策略实现了显著的恶性原位骨肉瘤治疗效果,且未观察到明显副作用。

本研究不仅提出了一种制备高性能碳氮化物基纳米催化剂的方法,还为临床实践中实现高效恶性骨肿瘤治疗提供了新策略。

展开英文摘要原文

Low immunogenicity, insufficient immune infiltrates, and inhibitive microenvironment of tumors ruthlessly weakened the therapeutic efficacy of immunotherapies. How to improve the therapy efficacy by reshaping the tumor immune microenvironment still remains a challenge that needs to be urgently addressed.

Here, a novel dual-defect nitrogen-rich carbon nitride-based heterostructural nanocatalyst (CNO@CuMS) possessing brilliant piezocatalytic H 2 O 2 generation, sonocatalytic 1 O 2 generation, Fenton-like catalytic •OH generation, and cell cuproptosis inducing properties are developed. Accompanied by the ultrasonic treatment, immunogenic cell death (ICD) and the subsequent releasing of damage-associated molecular patterns (DAMPs) of tumor cells are successfully triggered by CNO@CuMS, which resulted in the activation of systematic antitumor response and enhanced the infiltration of CD8 + cytotoxic T lymphocytes and natural killer (NK) cells at tumor site.

The large quantitatively generated reactive oxygen species (ROS) also promoted the polarization of M2-type macrophage to M1-type as well. Benefitting from this tumor immune microenvironment remodelling effect, remarkable malignant orthotopic osteosarcoma therapy efficacy is achieved employing CNO@CuMS + αPD-1 combination strategy under ultrasonic treatment, with no significant side effects are observed.

This research not only proposes a method to fabricate high proformance carbon nitride-based nanocatalyst but also provides a new strategy to realize highly efficient malignant bone tumor therapy during clinical practice.

论文信息

作者
Hu T、Hu C、Ji Y、Lu N、Ye L、Li M、Xia J、Xie D
单位
Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Medical College of Zhejiang University, Hangzhou, 310016, P. R. China.China
期刊
Advanced materials (Deerfield Beach, Fla.)2025 Sep
原文标识
PubMed 40468629 · DOI 10.1002/adma.202506363